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How innate lymphoid cells (ILCs) in the thymus and
gut become specialized effectors is unclear. The
prototypic innate-like gd T cells (Tgd17) are a major
source of interleukin-17 (IL-17). We demonstrate
that Tgd17 cells are programmed by a gene regula-
tory network consisting of a quartet of high-mobility
group (HMG) box transcription factors, SOX4,
SOX13, TCF1, and LEF1, and not by conventional
TCR signaling. SOX4 and SOX13 directly regulated
the two requisite Tgd17 cell-specific genes, Rorc
and Blk, whereas TCF1 and LEF1 countered the
SOX proteins and induced genes of alternate effector
subsets. The T cell lineage specification factor TCF1
was also indispensable for the generation of IL-22
producing gut NKp46+ ILCs and restrained cytokine
production by lymphoid tissue inducer-like effectors.
These results indicate that similar gene network
architecture programs innate sources of IL-17, inde-
pendent of anatomical origins.
INTRODUCTION
Innate lymphoid cells (ILCs) and innate-like T cells (ILTC)
producing interleukin-17 (IL-17) and IL-22 have emerged as the
central players in mucosal immunity (Spits and Di Santo, 2011).
Upon infection or alterations in cellular environments, ILCs lack-
ing clonal antigen receptors and T cells expressing gd TCR
rapidly produce effector cytokines and growth factors to
promote pathogen clearance and tissue repair (O’Brien et al.,
2009; Sonnenberg et al., 2011). gdTCR+ ILTCs, similar to adap-
tive ab CD4+ T cells, are segregated into effector subsets.
However, unlike ab T effectors, gdTCR+ effector subsets can
be classified by the germline-encoded TCR chains and they
are generated in the thymus (Jensen et al., 2008; Narayan
et al., 2012; Ribot et al., 2009). More than half of Vg2 TCR+
(designated as V2) gd T cells are intrathymically programmedto produce IL-17 (Tgd17) and express RORgt (Rorc), the primary
transcription factor (TF) controlling IL-17 and IL-22 expression in
all lymphocytes (Ivanov et al., 2006). The emergent immature
(CD24hi) gd thymocyte subsets are further distinguished by TF
networks that may specify effector fates. Most of these,
including the high-mobility group (HMG) TFs SOX4 and
SOX13, are expressed highly only at the early effector program-
ming phase, their expression subsiding once effector capacity
has been established at the mature (CD24lo) stage. Whether
this ‘‘early’’ wave of TFs dominantly programs ILTC subset func-
tion was unknown.
In addition to Tgd17 ILTCs, there are at least four other RORgt+
ILTC and ILC subsets producing IL-17 and/or IL-22: abTCR+
invariant NKT (Rachitskaya et al., 2008), lymphoid tissue inducer
(LTi)-like (Sawa et al., 2010; Takatori et al., 2009), natural killer
(NK) cell receptor expressing IL-22 producer (NKp46+ NCR22;
Luci et al., 2009; Sanos et al., 2009; Satoh-Takayama et al.,
2008; Vonarbourg et al., 2010), and ILC17 cells (Buonocore
et al., 2010), with the latter three subsets primarily localized in
the gut associated lymphoid tissues (GALTs). How ILTCs and
ILCs are programmed toward distinct effectors is not well under-
stood. In particular, whether they share a unifying genetic blue-
print for differentiation distinct from that specifying adaptive
helper IL-17+ T helper 17 cells (Th17) is unknown. To answer
these questions, we determined the mechanism of innate
effector programming of Tgd17 cells and its possible involve-
ment in GALT ILC differentiation. We showed that the HMG TF
TCF1 and LEF1, and their interacting partners SOX4 and
SOX13, are expressed at particularly high amounts in the precur-
sors of Tgd17 cells (Narayan et al., 2012). HMGTFs are transcrip-
tion complex architectural proteins that bind to related
sequences in the minor groove of DNA, and their cell-type-
specific combinatorial clustering at target genes cooperatively
controls transcription (Badis et al., 2009). TCF1, the nuclear
effector of WNT signaling, is the best characterized HMG TF
and is critical for T cell lineage specification downstream of
Notch (Germar et al., 2011; Weber et al., 2011). We show here
that the HMG TFs, not conventional TCR signaling, programmed
IL-17 production in gd ILTCs. Moreover, TCF1 controlled cyto-
kine production in postnatal GALT ILCs and was absolutelyImmunity 38, 681–693, April 18, 2013 ª2013 Elsevier Inc. 681
A B
C
D E
F G
Figure 1. SOX13 Is Essential for Tgd17 Generation
(A) Frequencies of activated and mature Vg2+ T cells in gdTCR+ cells in the spleen and thymus, respectively, of WT and Sox13/ mice. Representative data
(numbers within the gates represent percents of total) from one experiment of at least four are shown. Similar results were obtained with T-Sox13/mice (B6).
(B) The defects in Tgd17 generation originate in the thymus. LN and thymic mature (CD24lo) Vg2+ cells from WT and Sox13/ mice were analyzed for the
expression of RORgt and EOMES (an activator of Ifng transcription), cell surface CCR6 and CD27, and intracellular IL-17A and IFN-g in matV2 cells. Frequencies
less than 0.5% are left as blanks.
(C) Intracellular staining for IL-17 in splenic V2 cells isolated from mice 4 hr post-Zymosan administration.
(D) Left shows intracellular and nuclear staining for the twomarkers of Tgd17 cells, BLK and RORgt, in V2 thymocytes from neonatal mice at different maturational
stages. Right shows that staining of Abs to BLK and RORgt in CD4+ ab thymocytes was used as negative controls.
(legend continued on next page)
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HMG TFs Program Innate IL-17 Productionrequired for NCR22 ILC generation. These results identify shared
gene network architecture centered on TCF1 underpinning IL-17
and IL-22 production by ILTCs and GALT ILCs.
RESULTS
To determine whether a common gene network controls innate
lymphoid effector differentiation, we first identified genes selec-
tively required to generate V2 Tgd17 cells. Emergent gd ILTC
subsets are marked with gene expression profiles predictive of
their eventual effector functions upon thymic egress (Narayan
et al., 2012). Hence, the gd T effector subtype-specific core TF
networks were candidates for specifying innate effector lineage
fate. Tgd17 precursors, immature V2 (immV2, CD24hi) thymo-
cytes, express genes encoding three HMG TFs, Sox4, Sox13,
and Tcf7 (encoding TCF1) at the highest amounts, whereas the
HMG TF Lef1 is expressed at similar amounts relative to other
gd cell subsets (Narayan et al., 2012). Aside from Lef1, the
HMG TF expression precedes that of TCR (Melichar et al.,
2007; Schilham et al., 1997; Verbeek et al., 1995; Weber et al.,
2011; www.immgen.org). To determine whether this expression
pattern programs Tgd17 cell differentiation and function, we
examined gd T cell subsets in Sox13/ (Melichar et al., 2007),
Sox4-deficient, and Tcf7/ (Verbeek et al., 1995) mice and
determined HMG TF chromatin occupancies in ex vivo Tgd17
precursors.
Sox13 Programs V2 Cell Tgd17 Differentiation
We found that Sox13-deficiency eliminated all V2 Tgd17 cells,
whereas other gd effector subsets were largely intact (Figure 1).
Sox13was identified as a gd T cell-specific TF that interacts with
TCF1 and LEF1 (Melichar et al., 2007), potentially modulating
their function. Whereas all immature gdTCR+ thymocytes
express Sox13, Tgd17 precursors express the protein at the
highest level (see Figure S1A available online), with its expres-
sion rapidly extinguished upon thymic maturation (Narayan
et al., 2012). Thus, all alterations in ILTCs associated with the
absence of SOX13 must originate in the precursors or at the
CD24hi stage. In Sox13/ mice, the frequencies of CD44hi V2
cells were severely reduced in peripheral tissues, and CD24lo
mature (mat) V2 thymocytes were diminished to 50% of
the wild-type (WT) (Figures 1A; Figures S1B and S1C). The
numbers of other gd effectors were only marginally lower (Fig-
ure S1C; data not shown). Critically, the V2 cells that were
specifically absent in Sox13/ mice were RORgt+CCR6+
CD27CD44hiCD62L Tgd17 cells (Narayan et al., 2012). Fetal
and adult RORgt+ matV2 thymocytes, the immediate precursors
of peripheral Tgd17 cells, were missing (Figure 1B; Figure S1D),
while the number of immV2 cells was not significantly altered.
The remaining V2 cells in Sox13/ mice did not synthesize
IL-17 (or IL-17F, data not shown) ex vivo (Figure 1B), even after
stimulation with the TLR2 ligand, Zymosan (Figure 1C). These
results demonstrate that the high SOX13 expression in devel-(E) SOX13 partly regulates RORgt expression in CD24hi immV2 thymocytes. A
Rorc-Gfp substrate introduced toSox13/mice and intranuclear RORgt protein e
are shown.
(F) Intracellular staining for BLK in two maturation stages of Vg2+ and Vg2 gd th
(G) Intracellular staining for IL-17A in Sox13 Tg+ LN gd T cells. See also Figure Soping immV2 thymocytes is a critical factor in Tgd17 cell
differentiation.
The loss of V2 Tgd17 cells occurred in both the fetal and adult
Sox13/ thymus. Fetal-derived Vg4+ (V4) gd T cells are the alter-
nate IL-17 producers (Shibata et al., 2008). Vg4 gene rearrange-
ments, which predominate in early fetal stages, precede that of
Vg2 and the fetal Vg4 chain is paired with the germline encoded
Vd1TCR. While V4 Tgd17 cells were negatively impacted in the
fetal thymus by the absence of SOX13, these effectors were
present in neonatal and adult Sox13/ mice (Figures S1E–
S1G). This result suggests that despite the lineage and functional
relatedness (Narayan et al., 2012), developmental requirements
for V2 and V4 Tgd17 cells are distinct.
B lymphocyte kinase (BLK) is essential for Tgd17 development
(Laird et al., 2010). Ectopic Sox13 expression induces Blk
expression in ab thymocytes (Melichar et al., 2007) and among
gd T cells, BLK+ cells are the sole source of IL-17 during path-
ogen challenge (Laird et al., 2010; Narayan et al., 2012). In
Sox13/ mice, V2 Tgd17 precursors (immV2 cells) expressing
normal amounts of BLK were depleted and the BLK and RORgt
coexpressors were specifically absent (Figure 1D). Analysis of
RorcGfp/+:Sox13/mice showed decreased, but still significant,
transcription of Rorc in the mutant immV2 cells (Figure 1E).
These results suggested that SOX13-regulated BLK expression
at the immature stage is critical for Tgd17 cell differentiation. In
support of this interpretation, transgenic (Tg) expression of
Sox13 in all developing gd cells (Melichar et al., 2007) increased
the proportions of BLK+ gdTCR+ cells, as well as the amount of
BLK expression per cell, independent of TCR repertoire (Fig-
ure 1F). Correspondingly, more gd T cells in peripheral tissues
produced IL-17 (Figure 1G). This enhancement was pronounced
for V4 gd T cells (Vg2), whereas high ectopic Sox13 expression
was particularly detrimental for the survival of V2 cells that
express the highest endogenous amount of Sox13 (Melichar
et al., 2007), confounding their analysis in the gain-of-function
model system. The absence of V2 Tgd17 cells in Sox13/
mice and the increased IL-17 production from gd T cells by the
ectopic expression of SOX13 indicate that SOX13 is necessary
for programming IL-17 production in ILTCs.
Sox4 Regulates RORgt Expression and Is Necessary for
IL-17-Mediated Skin Inflammation
Thymic precursors lacking SOX4 also did not generate V2
Tgd17 ILTCs in vivo (Figure 2). SOX4 is expressed highly in T
and B cell precursors as well as in immature ab CD4+CD8+
double-positive (DP) and gd thymocyte subsets (www.immgen.
org). SOX4 is a transcriptional activator and was shown to also
physically interact with TCF1 and LEF1 (Sinner et al., 2007;
data not shown). We generated T-cell-specific Sox4-deficient
(T-Sox4/) mice to evaluate the function of SOX4 in ILTCs by
breeding CD2 promoter-driven Cre (CD2p-Cre) transgenic (Tg)
mice to Sox4fl/fl mice (Penzo-Me´ndez et al., 2007). Mature
adaptive ab thymocytes were generated in T-Sox4/ mice.decrease in Rorc transcription (top) as indicated by GFP expression from
xpression (bottom) is shown. Representative data from one of two experiments
ymocytes from LCKp-Sox13 Tg mice.
1.
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Figure 2. SOX4 Regulates RORgt Expres-
sion during Tgd17 Generation
(A) LN and mature thymic Vg2+ cells from WT
(CD2p-Cre:Sox4+/+) and T-Sox4/ mice were
analyzed for the expression of RORgt, CCR6, and
CD27 and intracellular IL-17 and IFN-g. Repre-
sentative data from one of four experiments is
shown.
(B) SOX4 regulates RORgt expression in immV2
thymocytes. The loss of Rorc transcription (top)
as indicated by the loss of GFP expression
from Rorc-Gfp substrate introduced to T-Sox4/
mice and intranuclear RORgt protein expression
(bottom) is shown. Representative data from one
of three experiments are shown.
(C) Overlayed histograms of RORgt staining in ab
DP thymocytes in WT and T-Sox4/ mice. The
shaded histogram is the internal negative control
for RORgt staining, gated on ab CD4+ thymocytes
that do not express Rorc.
(D) PASI scoring was used to quantify the
severity of psoriatic inflammation in IMQ treated
mice. See also Figure S2. Data is represented as
mean ± SEM.
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HMG TFs Program Innate IL-17 ProductionStrikingly, V2 Tgd17 ILTCswere not observed in T-Sox4/mice,
whereas other gd effector subsets were present (Figure 2A; data
not shown). As in Sox13/ mice, the V2 cells that were com-
pletely lost in peripheral lymphoid tissues were RORgt+CCR6+
CD27CD44hiCD62L Tgd17 cells (Figures 2A and 2B). RORgt+
CCR6+CD27lo matV2 thymocytes were virtually undetectable in
fetal and adult T-Sox4/ mice (Figure 2A; data not shown),
whereas immV2 cells were present in normal proportions (Fig-
ure S2A) and did not exhibit decreased rates of survival or prolif-
eration (Figure S2B). Accordingly, the remaining differentiated V2
cells in T-Sox4/mice did not produce IL-17 ex vivo (Figure 2A).
The block in Tgd17 cells correlated with a loss of Rorc transcrip-
tion (based on RorcGfp/+:T-Sox4/ mice) and RORgt protein
expression beginning in immV2 thymocytes (Figure 2B; Fig-
ure S2C). This loss was nearly absolute, more severe than the
decrease observed in Sox13/ mice (Figure 1E). In contrast,
RORgt expression in ab DP thymocytes was unaffected by the
loss of SOX4 (Figure 2C), indicating that SOX4 is a gd ILTC-
specific modulator of RORgt expression.
Tgd17 cells have been implicated in the dermal inflammation-
driven psoriasis-like disease in mice (Cai et al., 2011;
Pantelyushin et al., 2012). The disease can be induced by the
application of the TLR7 ligand Imiquimod (IMQ) to skin. Tgd17
cells residing in the dermis have been shown to be the primary
lymphoid responders responsible for the disease. To determine
whether SOX4 is necessary to generate pathogenic dermal
Tgd17 cells, we first assessed the distribution of gd T cell subsets
in the dermis of T-Sox4/mice. V2, but not V4, Tgd17 cells were
greatly reduced in T-Sox4/ dermal tissues before treatment
(Figures S2D and S2E). After topical application of IMQ for
5 days, we observed significant thickening, scaling, and
erythema in WT mice. However, T-Sox4/mice did not show
overt inflammation (Figures S2F and S2G), which was quantified
by the adapted Psoriasis Area and Severity Index (PASI) scoring
system (Figure 2D). The lack of inflammation was correlated with
significantly decreased proportions of V2 Tgd17 cells (Figures684 Immunity 38, 681–693, April 18, 2013 ª2013 Elsevier Inc.S2D and S2E) and CD11b+Gr-1+ neutrophils (Figure S2H) in
the treated T-Sox4/dermis.
Unlike the dermis, V2 Tgd17 cells were a minor population
relative to Vd1+IL-17+ V4 cells in skin draining LNs of resting
WT mice (Figures S2I and S2J). Vd1+IL-17+ V4 cells were
decreased in number in the fetal T-Sox4/ thymus (30% of
the WT number), and reduced but substantial numbers of these
fetal-derived effectors were found in adult T-Sox4/ thymus
and lymph nodes (LNs, Figure S2I; data not shown). V4 LN
T cells responded to IMQ, as indicated by an increase in the
proportion of IL-17 producers (Figure S2I). However, this
response, and the persistence of dermal V4 cells in T-Sox4/
mice (Figures S2D and S2E), was insufficient to precipitate the
fulminant inflammatory condition in the skin. In conjunction
with previously published reports (Cai et al., 2011; Pantelyushin
et al., 2012), these results indicate that SOX4-dependent V2
Tgd17 cells are the primary ILTCs mediating IMQ-mediated
skin inflammation. In addition, the results showed that fetal-
derived V4 Tgd17 cells, while acutely dependent on SOX13
during gestation, have compensatory mechanisms to bypass
the SOX4 requirement and replenish their numbers in peripheral
tissues in the absence of either TFs. In contrast, the ‘‘late’’ V2
Tgd17 cells are not produced in the absence of Sox4 or Sox13,
reinforcing the conclusion that these two ILTC subsets are
generated under distinct conditions and are not functionally
interchangeable.
TCF1 Restrains IL-17+ Cell Generation
Tcf7 is turned on by Notch signaling to specify the T cell fate
(Germar et al., 2011; Weber et al., 2011). Notch signaling also
controls GALT ILC differentiation (Lee et al., 2012; Possot
et al., 2011), raising the possibility that TCF1 is the core regulator
of innate effector differentiation. In the absence of TCF1, devel-
opment of thymic precursors and ab T cells is aberrant (Verbeek
et al., 1995). Although the total gd thymocyte number is not
significantly decreased in young Tcf7/ mice (Verbeek et al.,
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Figure 3. TCF1 Constrains Tgd17 Generation
(A) Deregulated IL-17 production in Tcf7/ mice. Differentiation of Tgd17
thymocytes was examined by analyses of RORgt and EOMES, CCR6 and
CD27, and intracellular IL-17A and IFN-g expression in mature (CD24lo) Vg1.1+
and Vg2+ gd T cells. Similar results were obtained when peripheral gd T cell
subsets were analyzed. Representative profiles from one of at least five
independent experiments, each with minimum of three mice per genotype, are
shown.
(B) Expression of CD27 expression on Tcf7/ immV2 thymocytes. A similar
trend for increased ratio of CCR6/CD27 was observed with other gd thymic
subtypes.
(C) Intranuclear staining for RORgt and LEF1 in LN Vg1.1+ (top) and Vg2+
(bottom) T cells from WT and Tcf7/ mice shows mutually exclusive
expression of the TFs and the loss of LEF1+ gd T cells when TCF1 is
nonfunctional. TCF1 expression, although biased, is not starkly separated
fromRORgt expressors in any gd T cell subsets. Staining controls are shown in
Figure S3E.
(D) Intranuclear staining for LEF1 in immature (CD24hi) and mature (CD24lo)
Vg2+ thymocytes from WT and Tcf7/ mice. See also Figure S3.
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extensively distorted (Figures S3A and S3B). In particular, thymic
and peripheral V2 cells exhibited skewed ratios of CCR6+
(marking Tgd17 cells) to CD27+ (IFN-g producers, [Ribot et al.,
2009]) populations, with the latter subset being undetectable in
some Tcf7/ mice (Figure 3A). More than 80% of Tcf7/ V2
cells produced IL-17, twice the frequency observed in WT V2
cells, and they were uniformly RORgt+ (Figure 3A). The bias
toward IL-17 production was not V2 cell-specific because the
number of thymicmature Vg1.1+ (normally IFN-g+) cells express-
ing IL-17 was also increased by >10-fold (Figure S3C). This
pattern was not observed in Tcrb/ mice (N.M., data not
shown), indicating that the deregulated effector programming
is not simply a consequence of the decreased production of
ab thymocytes in Tcf7/ mice.
In all thymic gd subtypes, the decreased expression of CD27
was already evident at the immature stage (Figure 3B). This
pattern, along with a relatively normal cell-cycle status of
Tcf7/ gd thymocytes (Figure S3D), suggested that the
proclivity of TCF1-deficient gd ILTCs toward the IL-17 effector
fate is an early developmental event, not a consequence of
altered maintenance of mature effectors. This interpretation
was further supported by the LEF1 expression pattern. LEF1
was a discriminatory regulator of gd effectors, as evidenced by
its mutually exclusive expression to RORgt in gd thymocytes
(Figure 3C; Figure 3E) and the partial and complete loss of
LEF1+ subsets in Vg1.1+ and V2 cells, respectively, when TCF1
was absent (Figures 3C and 3D), again starting at the immature
stage of differentiation (Figure 3D). Lef1 expression is primarily
controlled by TCF1 (Driskell et al., 2007). Given the precedent
that some TCF1 target gene expression can be inhibited by
SOX13 (Marfil et al., 2010; Melichar et al., 2007), high amounts
of SOX13 in immV2 thymocytes may interfere with TCF1-medi-
ated induction of Lef1. Consistent with this, immature gdTCR+
thymocytes from Sox13Tg mice expressed significantly lower
amounts of LEF1 and CD27 (Figure S3F). Taken together,
TCF1 is necessary for pan-gd T cell development (Figures S3G
and S3H), and it programs gd T effector subset differentiation,
promoting and inhibiting IFN-g and IL-17 production, respec-
tively, whereas SOX4 and SOX13 have the opposite function.
HMG TF Chromatin Occupancy
Fetal and adult immV2 thymocytes share the TF transcriptome
(Figures S4A and S4B). To determine whether HMG TFs directly
regulate the Tgd17 gene network, we examined their chromatin
occupancies at three gene loci (Blk, Rorc, and Il17a) that are
the hallmarks of Tgd17 cells, along with the ubiquitously active
Gata3 locus as a control, in ex vivo immature Vg2+ and Vg2
thymocytes. First, we established epigenetic chromatin modifi-
cations of the gene loci. For comparison, in vitro differentiated
adaptive Th1 and Th17 ab T cells were examined. Among gd
T cell subsets, Blk and Rorc are most abundantly expressed in
V2 cells (Narayan et al., 2012). Accordingly, the Blk and Rorc
loci were selectively enriched for active H3K4me3 (and acety-
lated H3, data not shown) modifications in immVg2+ cells.
Conversely, the Rorc locus was repressed in immVg2 cells as
indicated by H3K27me3 markings (Figure S4C). In contrast,
Il17a was decorated exclusively with repressive H3K27me3
chromatin marks in the immature gd thymocytes, consistentImmunity 38, 681–693, April 18, 2013 ª2013 Elsevier Inc. 685
Figure 4. ChIP Assay for TF Binding near the Transcriptional Regulatory Sites of Rorc, Blk, il17a, and Gata3 Loci
Immature Vg2+ and Vg2 thymocytes, the immediate precursors ofmature thymic effectors, were compared to in vitro differentiated control Th1 and Th17CD4 ab
T cells. Analysis of mature gd thymocytes was not possible due to their low numbers in mice. Graphs show quantitative PCR detection for relative enrichment of
target DNA sequences from ChIP using Abs to indicated TF and control IgG (Figure S4). The regions examined are described in Figure S4 legend. Quantitative
real-time PCR data are plotted as average percentage (%) of input ± SD from two independent experiments. Binding of the TFs to TCF consensus sequences at
the control MyoG promoter was undetectable in T cells (data not shown). See also Figure S4.
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HMG TFs Program Innate IL-17 Productionwith its restricted expression in mature gd thymocytes (Narayan
et al., 2012). These results indicate that the distinct effector gene
expression profiles of immature gd cell subsets are foremost
regulated at the chromatin level.
Next, we determined HMG TF occupancy of Blk, Rorc, and
Il17a loci. SOX13 was localized to the Blk and Rorc loci in imma-
ture Vg2+, but not Vg2, thymocytes (Figure 4). The low signals in
Vg2- thymocytes can be accounted for by low SOX13 protein686 Immunity 38, 681–693, April 18, 2013 ª2013 Elsevier Inc.expression in the cells (Figure S1A). Although SOX4 was
detected at all four loci assessed in gd thymocytes, only the
docking at the Rorc loci was conserved in ab Th17 cells. More-
over, SOX4 was particularly enriched at the Region 2 (R2) near
the transcription start site dedicated for RORgt production in
Vg2+ thymocytes (Ruan et al., 2011). These results supported
the above finding (Figure 2) that SOX4 is an essential regulator
of Rorc expression in Tgd17 cells.
Immunity
HMG TFs Program Innate IL-17 ProductionTCF1 was enriched at the Blk and Rorc loci in immature
Vg2+ cells, but not in immature Vg2 cells. TCF1 and LEF1
occupancy at the Il17a locus exhibited distinct modality with
TCF1 preferentially enriched at the intronic R2, previously
shown to be a docking region in ab T cells (Yu et al., 2011),
in both thymic subsets and LEF1 at the promoter upstream
R1, particularly in immature Vg2 thymocytes. Consistent
with the TCF1 chromatin occupancy in precursor cells (Weber
et al., 2011), TCF1 was found docked onto the Gata3 locus in
gd thymocyte subsets, but LEF1 was not. LEF1 was associated
with the Blk locus in Vg2+ thymocytes, presumably in the
RORgt fraction, based on the mutually exclusive expression
of RORgt and LEF1 in V2 thymocytes (Figure 3C). That LEF1
docking at the Blk locus is neutral to suppressive for transcrip-
tion is supported by a selective enrichment at the locus in ab
Th17 cells that do not express Blk. As expected, LEF1 was
excluded from the Rorc locus in Vg2+ thymocytes. Integrated
with the results from the genetic studies, these results indicate
that the HMG TFs are direct transcriptional regulators of the
Tgd17 genes. SOX13 and SOX4 cooperatively orchestrate
Tgd17 differentiation by primarily controlling Blk and Rorc tran-
scription, respectively. TCF1, implicated as a negative regu-
lator of Tgd17 cells, was associated with all the loci examined.
Its docking at the Rorc and Blk loci was Vg2+ cell-type-
specific, a pattern overlapping with SOX13 and SOX4, and
raises the likelihood that a combinatorial assortment of HMG
TFs at each target gene locus is directly controlling ILTC
effector fate specification.
Conventional TCR Signaling Alone Cannot Specify
Tgd17 Fate
A potential mechanistic explanation for the distinct global gene
expression profiles of immature gd effector subsets is that
different gTCR chains (for example, Vg1.1/Vg5 versus Vg2/
Vg4) convey different signals to establish diverse differentiation
programs. For extrathymic adaptive Th17 cell differentiation,
TCR signaling-induced IRF4 (Bru¨stle et al., 2007) and ITK-
NFAT (Gomez-Rodriguez et al., 2009) are critical regulators of
Rorc and Il17a expression, respectively. IRF4 is dispensable
for Tgd17 cell differentiation (Powolny-Budnicka et al., 2011).
The role of ITK in Tgd17 differentiation was unknown. Peripheral
Itk/ gd T cells were impaired in their Ca2+ response when they
were activated via TCR stimulation in vitro (Figure S5A), estab-
lishing ITK as a key signal integrator of gdTCR signaling. In the
absence of ITK, the transcriptomes of immV2 thymocytes
converged with other gd cell subsets, as indicated by principal
component analysis (PCA, Figure 5A) that clusters related popu-
lations based on the major components of gene expression vari-
ability. ITK signaling was responsible for 90% of the unique
immV2 thymocyte transcriptome (Figure S5B). However, the
characteristic TF profile of immV2 cells was mostly insulated
from change when ITK was absent, as shown by hierarchical
clustering (Figure 5B), correlating with the relatively normal
generation of Tgd17 cells in Itk/ mice (Figure S5C). These
results demonstrate that while Vg2TCR-ITK signaling is central
to the establishment of distinct transcriptomes of gd subsets it
is not responsible for the wiring of gd effector subset-specific
TF networks at the immature stage. Together, these results
indicate that the conventional TCR signaling pathways so farimplicated in adaptive Th17 differentiation do not dominantly
specify the Tgd17 cell fate.
To directly assess the role of the gdTCR in Tgd17 cell differen-
tiation, gd T effector development was tracked in Vg2 TCR Tg
mice where nearly all gd T cells express the identical Vg2 TCR
chain (Kang et al., 1998). Vg2 TCR Tg expression on the cell
surface is controlled by endogenous TCRd-chain gene rear-
rangement and expression. If the TCR is deterministic for
effector fate, expression of a functional Vg2+ TCR in all gd
T cells should enhance the generation of Tgd17 cells. The Tg
mice, however, did not produce a significantly enhanced number
of IL-17+ gd cells, nor could the Tcrg Tg expression in Sox13/
mice rescue the Tgd17 differentiation defect (Figure 5C). These
results indicated that specific Vg2 TCR signaling per se is not
the dominant determinant of effector lineage specification.
If the TCR signaling alone cannot specify ILTC effector fates,
an alternate possibility was that distinct effector programs are
preset at different developmental stages. To test whether T cell
developmental intermediates possess unique effector genera-
tive capacity, we compared the ability of the early c-Kit
(CD117)+ T progenitors (ETP) versus the late c-Kitneg DN3
precursors to generate Tgd17 effectors. ETPs (fetal and adult)
generated CCR6+CD27 Tgd17 V2 cells in the standard
OP9-DL1 culture system (Figure 5D). However, no significant
generation of CCR6+CD27 V2 cells was detectable from DN3
precursors. Further, the late precursors were markedly biased
to produce V1 and V2 CD27+ gd cells (Figure S5D; data not
shown). Together, these findings suggest that the maturational
state of the precursors, and not TCR signaling alone, is a key
determinant of Tgd17 effector lineage specification.
TCF1 Is Necessary for GALT ILC Differentiation
One implication of the dominance of the HMGTF network in ILTC
effector differentiation was that a similar regulatory gene network
may operate to generate GALT ILCs that lack clonal antigen
receptors. GALT ILCs express several HMG TFs at the
messenger RNA level. These include Tcf7, Sox4, and Tox (Aliah-
mad et al., 2010), though not Sox13 (Reynders et al., 2011; data
not shown). To determine whether HMG TF networks control
innate effector differentiation extrathymically, we first estab-
lished the ILC subset-specific expression pattern of TCF1 and
LEF1 proteins andAxin2, a canonical TCF1-WNT signaling target
that can serve as a reporter of TCF1 as a transcriptional activator
(Lustig et al., 2002). In mLN and splenic CD3CD19 cells, TCF1
was expressed highly in IL-7R+ subsets, with all IL-7RhiRORgt+
LTi-like ILCs uniformly positive. The majority of mLN IL-7R+
NKp46+ NCR22 cells also expressed TCF1 (Figures 6A and 6B;
Figure S6A), whereas <10% of the RORgtIL-7R was TCF1+.
Expression of TCF1 and CD4, a classic marker of LTi cells,
was mostly concordant, with only some CD4+IL-7Rlo-neg cells
lacking TCF1. LEF1, coexpressed with TCF1 in adaptive
T cells, was not expressed in LTi-like or NCR22 ILCs (Figure 6A),
paralleling its exclusion from gd thymocytes fated for IL-17
production (Figure 3C). Similar results were obtained with
neonatal intestinal lamina propria (LP) ILC subsets (data not
shown). Axin2 was variably expressed in TCF1+ ILC subsets,
with LTi-like ILCs (c-Kit+IL-7R+Lin, a4b7+/, >50% Axin2+)
considerably enriched for WNT signaling activity than in
NCR22 ILCs (10% Axin2+) (Figure S6B). These results indicateImmunity 38, 681–693, April 18, 2013 ª2013 Elsevier Inc. 687
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HMG TFs Program Innate IL-17 Productionthat although TCF1 is expressed in most, but not all ILCs, it is
likely to have broad activities beyond that of the canonical
WNT signaling transcriptional activator.
To determine the range of TCF1 function, ILC subset compo-
sition, and function in the small intestine, mLN and spleen of
Tcf7/ mice were examined. In Tcf7/ neonatal intestines
and spleens, NKp46+IL-7R+ NCR22 ILCs were specifically
absent, whereas CD4+ LTi-like ILCs were overrepresented pro-
portionally, but only marginally increased in numbers (Figure 6C;
data not shown). LTi-like ILCs are CCR6+CD25+ (Sawa et al.,
2010; Vonarbourg et al., 2010) and the frequency of the CCR6+
fraction was elevated, a trend that was already evident in
Tcf7+/ heterozygotes (Figure 6D). However, Tcf7/ LTi-like
ILCs lost CD25 expression, most likely indicating that as in
T cell precursors (Weber et al., 2011), TCF1 may be a positive
regulator of Cd25 transcription in ILCs.
In 3- to 4-week-old Tcf7/mice, the number of RORgt+ ILCs
was reduced to one third of normal in the mLN, whereas IL-7R+
CD3CD19RORgtneg-lo fraction was decreased to 10% of
normal (Figure 6E). As in neonates, NKp46+ ILCs were specifi-
cally depleted (Figures 6E and 6F; Figure S6C). These results
show that TCF1 is absolutely required for NCR22 cell generation,
whereas LTi-like ILC production per se appears less dependent
on TCF1. During Tgd17 differentiation, TCF1 dampened effector
capacity (Figure 3). To determine whether TCF1 functions simi-
larly in differentiated ILCs, we assessed the effector capacity
of Tcf7/ ILCs. All RORgt+ ILCs in Tcf7/ mice expressed
higher amounts of RORgt per cell (Figure 6G) and were capable
of enhanced IL-17 production (Figure 6H, top row). Upon activa-
tion with TLR2 agonist Zymosan, IL-17 and IL-22 production
from Tcf7/ LTi-like ILCs was significantly elevated (Figure 6H;
Figure S6C). Thus, as in gd ILTC development, TCF1 has a dual
function in ILC development, coordinating normal gene induc-
tion to ensure proper differentiation of ILC subsets and control-
ling effector function by restraining RORgt expression and
IL-17 and IL-22 production.
DISCUSSION
We showed that dermal SOX13 and SOX4-dependent V2 Tgd17
cells are the primary innate lymphoid mediators of psoriasis-like
disease in C57BL/6 mice and they develop in the thymus under
the control of a HMG TF regulatory network. Adaptive Th17 cell
differentiation in peripheral tissues requires TCR signaling and its
downstream targets ITK (Gomez-Rodriguez et al., 2009) and(A) PCA of the discriminatory gene signature of Itk/ immV2 cells. PCA of the 15%
labels indicate population; MEV > 120 in at least one population; 1,433 genes)
proportion of the total variability represented by each component (in parenthese
(B) A heat map of relative gene expression of TFs in immature gd subsets fromWT
gene and subset. Genes are color coded (see legend) to display relative gene ex
(C) LN cells fromWT and Tcrgv2 transgenic mice (with and without normal Sox13)
were analyzed for the expression of Vg2 in gd T cells (top) or intracellular IL-17A in
shown, each with a minimum of three/group. Similar results were observed with
(D) gd T cell progenies of c-Kithi ETPs and c-Kit DN3 (CD25+CD44CD3CD4
CCR6 and CD27 expression. Representative FACS plots of V2 cells (top) and a s
Tgd17 cells generated from ETPs (103 cells per well) or DN3 (53 103 cells per well
per well. Average cell numbers obtained from DN1 or DN3 were 3.53 105 or 4.63
independent experiments, ETP n = 18; DN3 n = 38. See also Figure S5.IRF4 (Bru¨stle et al., 2007), the inflammatory cytokine IL-6 and
its signal mediator STAT3 (Zhou et al., 2007), as well as TGF-
b-activated SMAD2 (Malhotra et al., 2010). None of these factors
are essential for Tgd17 ILTC development in the thymus (Lochner
et al., 2008; Malhotra et al., 2010; Powolny-Budnicka et al.,
2011). Instead, a complex network of HMG TFs cooperatively
controls thymic ILTC differentiation by direct regulation of key
genes involved in effector function. Among them, SOX4 and
SOX13 are the central positive regulators of Tgd17 differentia-
tion, by primarily inducing RORgt and BLK, respectively, and
potentially localizing their interacting partner TCF1 to select
chromatin sites. Given that HMG TFs operate in conjunction
with cofactors, a detailed understanding of target gene-specific
function of SOX4 and SOX13 awaits the full characterization of
transcriptional complexes assembled by each factor.
During early fetal dendritic epidermal gd T cell (Vg3+) differen-
tiation, cell surface SKINT signaling normally suppresses Rorc
and Sox13 expression to block IL-17 production (Turchinovich
and Hayday, 2011), underscoring the importance of SOX13 in
positively enforcing the IL-17 effector fate that must be circum-
vented to generate alternate innate effector cells in the fetus.
SOX13 regulates several key factors of V2 Tgd17 cell differenti-
ation, including Blk, Rorc, and Etv5 (K.E.S., data not shown).
The exclusion of LEF1 from developing Tgd17 cells is also likely
to be established by SOX13, as suggested by the diminished
Lef1 expression in Sox13Tg mice. Although published studies
to date support protein-protein interactions as the main regula-
tory mode of SOX13-TCF1 functions, it remains possible that
each can impact chromatin occupancy of the other. For
instance, the loss of TCF1 may result in more precursors
with SOX13 bound to the Rorc locus, thereby leading to the
enhanced generation of Tgd17 cells. However, Tcf7/ gd cells
do not express LEF1, and the loss of LEF1-dependent effector
developmental potential may also indirectly enhance Tgd17
cell production. A systemic approach that can simultaneously
track all relevant HMG TFs during Tgd17 differentiation from
thymic precursors will be necessary to define the rules governing
functional connectivities of HMG TFs.
Themechanism by which the temporally disparate emergence
of gd effector subtypes is linked to specific TCRg and d repertoire
remains to be determined. We have identified ITK as a discrimi-
natory signal mediator of TCR that is required for the molecular
divergence of V2 cells from other gd cell subsets. Previously, it
has been shown that some IL-17+ Vg2+ T cells can be generated
in the absence of ligand recognition, whereas TCR triggering ledmost variable genes among the populations of cells shown (colors of bars and
. The first three principal components (PC1–PC3) are shown, along with the
s along axes).
and Itk/mice. Data were gene row normalized and hierarchically clustered by
pression.
that express a functional Vg2-Jg1-Cg1 (Tcr Vg2 Tg) chain in nearly all gd T cells
Vg2+ T cells (bottom). Representative profiles from one of two experiments are
thymocytes.
CD8) precursors cultured on OP9-DL1 stromal monolayers were assayed for
ummary of the frequencies (bottom, Student t test p values) of CCR6+CD27
) precursors are shown. Similar results were obtained with varying cell numbers
104 per well, respectively. V1/V6 = Vg1.1+ cells. Data are combined from three
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Figure 6. TCF1 Regulates the Differentiation and Function of GALT ILCs
(A) TCF1/LEF1 expression in CD3CD19 mLN ILCs of adult mice. ILCs were segregated based on RORgt and IL-7R expression. CD4, NKp46,
intranuclear TCF1, and LEF1 expression was assessed on the three indicated subsets. Data shown are representative profiles from one of three independent
studies.
(legend continued on next page)
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HMG TFs Program Innate IL-17 Productionto the capacity to produce IFN-g (Jensen et al., 2008). In vitro
assays, however, showed that the cell surface expression of
Vg2TCR itself is uniquely able to trigger signaling, akin to the
pre-TCR signaling that generates ab DP cells. Given the
substantial, but constrained, alterations of V2 cells in Itk/
mice, we propose that the Vg2TCR-ITK signaling constitutes
a developmental checkpoint related to the b selection for ab
thymocytes but that this tonic signaling alone does not regulate
the TF transcriptome that programs the Tgd17 effectors.
Published data (Jensen et al., 2008; Ribot et al., 2009; Turch-
inovich and Hayday, 2011) and our results from the in vitro
cultures and TCRg Tg mice indicate at least two other factors
that can contribute to the observed correlation between TCR
repertoire and effector function: developmental timing and
limiting permissive niches. In the OP9 culture system, DN3 cells
and their progenies cannot generate Tgd17 cells, indicating
a developmental stage-specific gene program, perhaps linked
to an ordered Tcrgv gene rearrangement process. However,
the enforced expression of Vg2TCR does not enhance the
number of Tgd17 cells generated in vivo, indicating that
Vg2TCR-specific signals alone cannot dictate effector fate and
that there exists a limit to the number of Tgd17 cells that can
be produced regardless of the TCR repertoire.
Recently, it has been concluded that most Tgd17 cells are
generated during gestation (Haas et al., 2012). Although this
can account for the correlation for V4 cells, whether V2 Tgd17
cells also originate exclusively during gestation remains to be
clarified. The requirements for SOX4 and SOX13 in the genera-
tion of V2 and V4 Tgd17 cells are distinct, with V2 Tgd17 cells
showing an absolute dependence, whereas V4 Tgd17 cells are
mostly dependent on SOX13, but even here only the fetal thymic
cellularity was significantly impacted by the loss of Sox13. These
distinct developmental requirements between V2 and V4 cells
are observed despite their overall molecular similarity at the
gene expression level (Narayan et al., 2012), suggesting T cell-
extrinsic environmental signals differentially affecting the early
(Vg4+) versus late (Vg2+) Tgd17 cell development.
The high Tcf7 expression is a unifying feature of developing
thymocytes and GALT ILCs. Notch signaling has been shown
to directly induce Tcf7 transcription (Germar et al., 2011; Weber
et al., 2011). On the basis of the known targets of TCF1 in T cells
and their precursors, TCF1 may directly regulate the expression
of several markers of GALT ILCs, including Id2 (Germar et al.,
2011; Rockman et al., 2001), Il7r (Germar et al., 2011), Cd4
(Huang et al., 2006), and Cd25 (Weber et al., 2011). For ILCs,
Tcf7-deficiency led to the selective loss of NCR22 cells that(B) TCF1 expression in CD3CD19CD11b mLN ILCs segregated based on NK
(C) TCF1 is required for the development of NCR22 cells. Intestinal LP and spleni
NKp46 to track NCR22 cells. Data shown are representative profiles from one o
(D) Frequencies of CCR6+ and CD25+ in neonatal LP ILCs from Tcf7+/ heteroz
p values are shown. Similar results were observed in mLN.
(E) Numerical reduction in the ILC subsets in the mLN of 3-week-old Tcf7/mice
and Nkp46 RORgtlo ILCs is shown. Data are combined from two experiments,
(F) Representative histograms showing the frequency of NCR22 cells in the mLN
(G) Increased expression of RORgt in Tcf7/ ILCs. Averages of MFI (±SEM) of RO
one representative experiment of four).
(H) TCF1 restrains IL-17 and IL-22 production in the ILCs. Intracellular staining for I
perfomed post-Zymosan administration. Unlike in other tissues, the number of
shown were obtained in two additional experiments. See also Figure S6.have been shown to be most dependent on Notch signaling for
development (Lee et al., 2012). Other RORgt+ ILCs are mostly
spared, although their functional profiles are altered when
TCF1 is absent, as evidenced by the hyper production of cyto-
kines, reminiscent of Tcf7/ gd ILTCs. Thus, TCF1 is a negative
regulator of IL-17 and IL-22 production in differentiated innate
lymphoid effectors. An analogous (Yu et al., 2011) or distinct
(Muranski et al., 2011) function of TCF1 in adaptive T cells has
been proposed, but in vivo, TCF1 may primarily impact Th17
cell survival or renewal. This difference in the repertoire of
TCF1 function in innate versus adaptive lymphocytes is likely
linked to the dominance of TCR and cytokine receptor signaling
in specifying adaptive effector differentiation, whereas the
production of fast-acting innate lymphoid effectors is acutely
dependent on intrinsic gene networks programmed in the
tissues of origin. TCF1may also be required for fetal LTi develop-
ment as Tcf7/ mice do not generate Peyer’s patches (N.M.
data not shown), similar to mice lacking the HMG TF Tox (Aliah-
mad et al., 2010). Together, these results suggest that the diver-
sity of RORgt+ innate lymphoid subsets can be generated by
unique combinatorial usage of HMG TFs in precursors arising
in distinct tissues.
EXPERIMENTAL PROCEDURES
Mice
Sox13/ (129/J), Sox13 Tg (Melichar et al., 2007), TcrVg2 Tg (C57BL/6) (Kang
et al., 1998), Axin2lz/+ (H. Birchmeier, MDC Berlin), Tcrb/, Rorc-Gfp (JAX),
Itk/ (Felices et al., 2009), and Tcf7/mice (Verbeek et al., 1995) were previ-
ously described. Sox4fl/fl mice were generated by V. Lefebvre (Penzo-Me´ndez
et al., 2007) and crossed to CD2p-CreTg mice. All mice were housed in a
specific pathogen-free barrier facility and experiments performed were
approved by the IACUC.
Flow Cytometry
Antibodies (Abs) used are detailed in Supplemental Information. Data was
acquired on a BD LSRII cytometer and was analyzed by using FlowJo
(Treestar).
Ex Vivo Stimulation, Zymosan Activation, and OP9 Culture
Freshly isolated thymic and LN cells were cultured (2 3 106/well) with PMA
(10 ng/ml) and Ionomycin (1 mg/ml) for 4 hr at 37C, with Golgi Stop and Golgi
Plug (BD Biosciences) added after 1 hr. After stimulation, cells were stained for
cell surfacemarkers and intracellular cytokine production by using the Cytofix/
Cytoperm kit (BD Biosciences). To activate innate effectors, we injected mice
intraperitoneally with Zymosan (Sigma) in PBS (6 mg/mouse). Four hrs postin-
jection, lymphocytes were isolated from the mLN and spleens. Cells were
stimulated with PMA/Iono and intracellular staining for IL-22 and IL-17 in gd
ILTCs and ILCs was performed. Intestinal LP lymphocytes from 10-day-oldp46 and IL-7R was analyzed.
c ILCs (CD3CD19IL-7R+) from Tcf7/ neonates were stained with CD4 and
f four studies.
ygotes (HET) and Tcf7/ mice. Lines represent the mean, and Student t test
. The total cell number of IL-7R+ ILCs, RORgthi and RORgtlo ILCs, and Nkp46+
n = 5/group. Data are represented as mean ± SEM.
s of 3-week-old Tcf7/ mice.
Rgt expression in the CD3CD19IL-7Rhi spleen cells is provided (n = 5/group;
L-17 and IL-22 in the ex vivo splenic ILCs (CD3CD19IL-7RhiCD4+CD25+) was
splenic RORgt+ ILCs was marginally increased in adult Tcf7/ mice. Profiles
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ETPs (c-Kit+CD4CD8CD3CD25CD44+) or c-Kit DN3 (CD4CD8CD3
CD25+CD44) cells were plated onto OP9-DL1 monolayers (J. C. Zuniga-
Pflucker) at various concentrations in aMEM media containing 20% FBS
(GIBCO), 1 ng/ml IL-7 (R&D Systems), and 5 ng/ml Flt3L (R&D Systems). After
5–12 days of culture, cells were analyzed by flow cytometry.
Psoriasis Induction
Aldara (5% Imiquimod, 3M Pharmaceuticals) or control vehicle cream was
applied daily for five days on the back and ear. The disease severity in mice
was scored by amodified PASI normally used to rank human psoriasis severity
(Fredriksson and Pettersson, 1978). The scale thickness and erythema were
scored from 0 to 4 (slight, moderate, severe, very severe), and the total area
of the inflammation covering the back was scored from 0 to 6 (0%, 10%–
29%, 30%–49%, 50%–69%, 70%–89%, 90%–100%). The scores for the
scales and erythema were added and multiplied by the score for the body
area to obtain the total score ranging from 0 (no disease) to 48. Dermal cells
were obtained according to a published protocol (Suffia et al., 2005).
Microarray Analysis
Samples were processed and analyzed according to the standard operating
protocol of the Immunological Genome Project (www.immgen.org; Supple-
mental Information); GEO:GSE15907.
Chromatin Immunoprecipitation Assay
Sorted immature Vg2+ and Vg2 thymocyte subsets were used to determine
HMG TF chromatin occupancy at the Blk, Rorc, Il17a, and Gata3 loci using
commercially available Abs, reagents, and kits. In vitro differentiated Th1
and Th17 cells were used as controls. Detailed method is provided in Supple-
mental Information.
SUPPLEMENTAL INFORMATION
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